Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 21

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 241–252 of 391 articles

Medium impact AnalysisMay 27, 2026

FDA Delays Ruling on AstraZeneca’s Breast Cancer Drug: Implications for Pharma

FDA · breast cancer · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 27, 2026

Gilead's Hepcludex Secures FDA Approval: Implications for Pharma

FDA · hepatitis · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 27, 2026

FDA vs EMA: The Camizestrant Controversy

FDA · oncology · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 27, 2026

Astellas Cuts Costs Amid FDA Review of Moderna Vaccine

FDA · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 27, 2026

Mirum Maps FDA Path After Anti-Itch Candidate Scores Phase 2 Win

FDA · oncology · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 27, 2026

Praise for FDA’s Acting Commissioner: Implications for Pharma

FDA · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 26, 2026

FDA Grants Early Access to Promising Drug for Pancreatic Cancer

FDA · oncology · 4 min

Dr. Sarah Mitchell
Medium impact NewsMay 26, 2026

FDA's New Form 483 Response Guidance: Implications for Pharma

FDA · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 26, 2026

Kyle Diamantas: Rising to Lead the FDA Against All Odds

FDA · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 25, 2026

FDA Approves Expanded Access for Daraxonrasib in Pancreatic Cancer

FDA · oncology · 4 min

Dr. Sarah Mitchell
Medium impact NewsMay 25, 2026

FDA Drug Approval Decisions Expected in May 2026: What to Anticipate

FDA · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 23, 2026

AstraZeneca and Daiichi Secure FDA Approval for Datroway in TNBC

FDA · TNBC · 3 min

Dr. Sarah Mitchell